The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
about
Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain n-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs.Perspective on the dynamics of cancer.Macrocyclic Inhibitors of ERK2 Kinase.microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review.ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV(pic) in Focal Cerebral Ischemia-Reperfusion Injury.
P2860
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
@en
type
label
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
@en
prefLabel
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
@en
P2093
P2860
P356
P1476
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy
@en
P2093
P2860
P304
P356
10.4155/FMC.14.143
P50
P577
2015-01-01T00:00:00Z